Josep Lupón Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

1/2023

Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josep Lupón Research Topics

Disease

93	Heart Failure 11/2023 - 02/2004
13	Fibrosis (Cirrhosis) 01/2023 - 01/2012
11	Inflammation (Inflammations) 10/2022 - 04/2015
7	ST Elevation Myocardial Infarction 09/2023 - 12/2017
4	Iron Deficiencies 01/2022 - 01/2019
3	Disease Progression 01/2023 - 02/2016
3	Left Ventricular Dysfunction 06/2022 - 01/2018
3	Obesity 01/2022 - 11/2019
3	Anemia 10/2020 - 02/2004
3	Chronic Renal Insufficiency 10/2020 - 03/2014
2	Cardiomegaly (Heart Hypertrophy) 11/2023 - 01/2021
2	Hypertrophy 11/2023 - 01/2021
2	Neoplasms (Cancer) 06/2022 - 01/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 04/2004
2	Pulmonary Hypertension 01/2022 - 11/2018
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2022
2	Infarction (Infarctions) 01/2022 - 01/2020
2	Aortic Valve Stenosis (Aortic Stenosis) 12/2020 - 06/2019
2	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 03/2020 - 11/2018
2	Diabetes Mellitus 11/2019 - 03/2013
2	Atrial Fibrillation 08/2019 - 06/2012
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2017 - 02/2016
2	Bundle-Branch Block (Fascicular Block) 02/2016 - 04/2015
2	Systolic Heart Failure 07/2015 - 04/2015
2	Renal Insufficiency (Renal Failure) 11/2013 - 12/2007
2	Hypertension (High Blood Pressure) 12/2007 - 11/2007
1	Type 2 Diabetes Mellitus (MODY) 03/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Atherosclerosis 01/2023
1	Amyloidosis 11/2022
1	Cardiotoxicity 06/2022
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Alcoholic Cardiomyopathy 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Overweight 01/2021

Drug/Important Bio-Agent (IBA)

35	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2012
17	Troponin T (Troponin T1)IBA 01/2023 - 03/2013
17	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2012
17	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 01/2012
15	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 02/2015
7	Trinitrotoluene (TNT)IBA 01/2023 - 04/2017
6	CreatinineIBA 03/2014 - 02/2004
5	Hemoglobins (Hemoglobin)IBA 09/2016 - 02/2004
4	TroponinIBA 01/2023 - 11/2013
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 03/2010
4	Natriuretic PeptidesIBA 01/2022 - 07/2012
4	SodiumIBA 01/2021 - 01/2012
4	Galectin 3 (LGALS3)IBA 04/2015 - 01/2014
3	AntigensIBA 04/2022 - 01/2020
3	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2020
3	empagliflozinIBA 01/2022 - 11/2019
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 02/2015
3	IronIBA 10/2020 - 01/2019
3	Angiotensin Receptor AntagonistsIBA 01/2018 - 03/2010
3	Cystatin CIBA 11/2014 - 01/2012
2	Atrial Natriuretic Factor (ANF)IBA 11/2023 - 11/2022
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2023 - 01/2021
2	Peptides (Polypeptides)IBA 01/2023 - 11/2017
2	procollagen type I carboxy terminal peptide (PICP)IBA 01/2023 - 06/2022
2	CarbohydratesIBA 04/2022 - 01/2021
2	pirfenidoneIBA 01/2022 - 01/2022
2	Transferrin (beta 2 Transferrin)IBA 10/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2020
2	Ferritins (Ferritin)IBA 10/2020 - 01/2019
2	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 03/2020 - 11/2018
2	C-Reactive ProteinIBA 01/2020 - 04/2015
2	DiureticsIBA 01/2020 - 02/2004
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020 - 11/2018
2	CholesterolIBA 06/2012 - 02/2004
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012 - 03/2010
2	MyostatinIBA 12/2010 - 08/2010
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2023
1	N-propionylprocainamideIBA 11/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2023
1	Fatty Acid-Binding ProteinsIBA 03/2023
1	Procollagen Type IIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	evolocumabIBA 01/2023
1	Proprotein Convertase 9IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	LDL CholesterolIBA 01/2023
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2022
1	AcetylglucosamineIBA 10/2022
1	GalactosamineIBA 10/2022
1	Protons (Proton)IBA 10/2022
1	AnthracyclinesIBA 06/2022
1	ProcollagenIBA 06/2022
1	Connexin 43 (Connexin43)IBA 01/2022
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021

Therapy/Procedure

12	Therapeutics 01/2023 - 06/2007
7	Percutaneous Coronary Intervention 09/2023 - 12/2017
4	Patient Readmission 01/2020 - 04/2005
2	Drug Therapy (Chemotherapy) 06/2022 - 01/2016
1	Immunotherapy 01/2023
1	Cardiac Resynchronization Therapy 01/2021